Weiss Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Sell
2,603
-50,068
-95% -$18.6M 0.01% 427
2026
Q1
$15.4M Sell
52,671
-61,253
-54% -$20.1M 0.26% 85
2025
Q4
$39.9M Sell
113,924
-22,041
-16% -$7.45M 0.53% 34
2025
Q3
$43.9M Buy
+135,965
New +$42.3M 0.51% 30
2022
Q2
Sell
-7,915
Closed -$3.89M 691
2022
Q1
$3.89M Buy
+7,915
New +$3.62M 0.08% 310
2021
Q3
Sell
-9,120
Closed -$3.48M 538
2021
Q2
$3.48M Buy
+9,120
New +$3.49M 0.09% 245
2020
Q1
Sell
-841
Closed -$254K 242
2019
Q4
$254K Sell
841
-266
-24% -$73.2K 0.02% 163
2019
Q3
$266K Buy
1,107
+352
+47% +$96.4K 0.02% 214
2019
Q2
$213K Buy
+755
New +$206K 0.01% 204

Other funds holding ELV

Weiss Asset Management's ELV Position: Q2 2026 in Review

Weiss Asset Management reduced its Elevance Health (ELV) stake by 95% in Q2 2026, selling an estimated $18.6M and leaving 2,603 shares worth $1.01M. The position accounts for 0.01% of the portfolio, ranked #427.

Weiss Asset Management first reported a position in ELV in Q2 2019 and has held it in 9 quarters since. The position peaked at $43.9M in Q3 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Weiss Asset Management held 2,603 shares of Elevance Health worth $1.01M as of Q2 2026.
  • Weiss Asset Management sold 50,068 Elevance Health shares in Q2 2026, an estimated $18.6M.
  • Elevance Health made up 0.01% of Weiss Asset Management's portfolio in Q2 2026, its #427 holding.
  • Weiss Asset Management first reported a position in Elevance Health in Q2 2019 and has held it in 9 quarters since.
  • Weiss Asset Management's Elevance Health position peaked at $43.9M in Q3 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Weiss Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.